Inflammatory and atherosclerotic interactions in the depleted uremic patient.
about
Total and corrected antioxidant capacity in hemodialyzed patientsGenetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunctionComparison of classical and non-classical cardiovascular risk factors influencing the patency of native arteriovenous fistulas after percutaneous transluminal angioplasty therapy among haemodialysis patientsMedical and Periodontal Clinical Parameters in Patients at Different Levels of Chronic Renal FailureThe Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes. A Narrative Review, Towards a Personalized, Patient-Centered Approach.Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients.Inflammation in end-stage renal disease: sources, consequences, and therapy.Ultrafiltration and dry weight-what are the cardiovascular effects?Body mass index, mortality, and gender difference in advanced chronic kidney disease.Cachexia and protein-energy wasting in children with chronic kidney disease.Pretransplant malnutrition, inflammation, and atherosclerosis affect cardiovascular outcomes after kidney transplantation.Biochemical and clinical evidence for uremic toxicity.Plasma S100A12 levels and peripheral arterial disease in end-stage renal diseaseThe relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients.Association of peripheral arterial disease with all-cause and cardiovascular mortality in hemodialysis patients: a meta-analysis.A meta-analysis on correlation between interleukin-6 -174G/C polymorphism and end-stage renal disease.Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients.Inflammation regulates fibroblast growth factor 23 production.Aspects of immune dysfunction in end-stage renal diseaseRenal anemia of inflammation: the name is self-explanatory.Depression and mortality in end-stage renal disease.Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase.Ironing out the cross talk between FGF23 and inflammation.Peri-aortic fat tissue and malnutrition-inflammation-atherosclerosis/calcification syndrome in end-stage renal disease patients.Elevated serum interleukin-18 levels might reflect the high risk of hospitalization in patients on peritoneal dialysis.Effect of omega-3 supplementation on inflammatory parameters in patients on chronic ambulatory peritoneal dialysisOxidized low density lipoprotein exposure alters the transcriptional response of macrophages to inflammatory stimulus.Prevalence of erectile dysfunction in chronic renal disease patients on conservative treatment.Expression of Hsp72 protein in chronic kidney disease patients.Oxidative stress in renal transplant patients who develop cardiovascular disease.Tissue factor and thrombomodulin in hemodialysis patients: associations with endothelial injury, liver disease, and erythropoietin therapy.Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5/6 nephrectomized rats: role of phospholipase and cyclooxygenase.Intravenous iron gluconate administration increases circulating PAPP-A in hemodialysis patients.Anti-inflammatory activity of Korean folk medicine purple bamboo salt.Influence of parenteral iron therapy and oral vitamin E supplementation on neutrophil respiratory burst in chronic hemodialysis patients.Inflammatory cytokines and malnutrition as related to risk for cardiovascular disease in hemodialysis patients.The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease.Malnutrition, Inflammation, Atherosclerosis Syndrome (MIA) and Diet Recommendations among End-Stage Renal Disease Patients Treated with Maintenance Hemodialysis.Targeting Immunity in End-Stage Renal Disease.Adsorption as a Contributor for Inflammatory Mediators Removal by Different Hemofiltration Membranes: A Pilot Study.
P2860
Q24791714-16136A21-60A9-4003-99E3-A3CB385451ABQ26824460-7A25DB10-3C8E-4F70-9A58-124C25BA9E7DQ28219151-5E9B8C36-5923-4E7F-AC65-B663C3700120Q33572228-B291E644-FF9C-4077-A4B1-4046F7D167F8Q33616803-FC8E8AA8-9DD6-4E02-BD31-9E0B876DA82DQ34751797-C672501C-8025-4595-A060-637A277EF3CEQ34928704-E5199BCE-9849-4BDD-A57C-FF8614004D3AQ35093661-8D5EC41F-FC4F-416E-8858-F23A6A6AE67AQ35571137-3586E508-6CC9-488E-B78E-4DA770104831Q35645564-A99E820E-B96B-4E9C-BA1D-8DE0FA1F8E13Q35700844-E51839C4-EE0A-4637-B69D-C24BDE436CC5Q35717674-1F092991-88B2-49AF-914E-103D25216D23Q35791729-A64443C7-3291-4865-8125-A0881ED86979Q35985760-4CDC4D5B-03EA-4C95-8049-D7AAB3B7E938Q36204177-643DE608-E2D9-4ED3-8438-55ED4786F90EQ36271220-98AD574A-FC96-4CCF-9391-A9D709489205Q36652781-EA5AB024-94E4-4CED-BD77-B55B340C3375Q37243107-40451EFF-5AB3-49E0-A2CD-7970B0F8337BQ37243143-E2B4F9DC-3455-4F5C-B09C-64E709B8B4B9Q37914623-392F74E6-2FC9-4F48-9001-0583F4AD5A17Q37959308-30D69B37-F42D-4A4F-BB90-286A7EEBF84FQ38283016-B4F2B901-2160-4573-90D7-661BE635333FQ38942965-EE3604E0-937C-4AFB-94F8-F4C3897F8273Q39548668-472D35F6-B758-47CE-A043-4FB69D4BA309Q40365204-F461799B-9D0F-4777-95F6-FB6E63D8AB7AQ40467967-5EC3C351-6564-4229-9AA5-A17A1EBE6186Q40778017-935E633F-932B-4F4A-BF2E-71D1A426D0B2Q40940279-1838285F-ED96-4518-9433-2BA74860B051Q43239649-3EE78478-156B-4ACD-834B-12CE43F67B0AQ43945110-3E168A39-6AC9-4EC3-B17B-383CD6A8C9BAQ44265769-A8BBE86F-8E0B-4CB6-A593-2DB81A77DE11Q44970228-C3BEB3C9-555A-4BE0-96A4-2467CD9CEA93Q45250531-D95C00C9-729B-4BC6-84A1-4B13E6DD35B6Q46139995-9FE0E937-AF65-4F89-8F17-42C2D555A42AQ46418925-5DAF419E-20E5-4195-8DD8-0D3968D944A0Q46640283-22733A91-C951-4E13-858F-6C26D0EEBC37Q47235026-C883A543-F51F-48A0-938E-976AD7D29B9FQ48260344-2A004DC7-9E4E-4537-9E5F-A80CFAE45E03Q50872135-8270C1E2-86EC-4A2C-B0E7-8B341EAD857AQ51031594-773DBEA4-AB48-4E68-9827-FD45B0C74B4B
P2860
Inflammatory and atherosclerotic interactions in the depleted uremic patient.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inflammatory and atherosclerotic interactions in the depleted uremic patient.
@ast
Inflammatory and atherosclerotic interactions in the depleted uremic patient.
@en
Inflammatory and atherosclerotic interactions in the depleted uremic patient.
@nl
type
label
Inflammatory and atherosclerotic interactions in the depleted uremic patient.
@ast
Inflammatory and atherosclerotic interactions in the depleted uremic patient.
@en
Inflammatory and atherosclerotic interactions in the depleted uremic patient.
@nl
prefLabel
Inflammatory and atherosclerotic interactions in the depleted uremic patient.
@ast
Inflammatory and atherosclerotic interactions in the depleted uremic patient.
@en
Inflammatory and atherosclerotic interactions in the depleted uremic patient.
@nl
P356
P1433
P1476
Inflammatory and atherosclerotic interactions in the depleted uremic patient
@en
P356
10.1159/000014479
P577
2001-01-01T00:00:00Z